Identification of donor microbe species that colonize and persist long term in the recipient after fecal transplant for recurrent Clostridium difficile

npj Biofilms and Microbiomes

Volumn 3, Issue 1, 2017, Pages

  Kumar, Ranjit ^a   Yi, Nengjun ^a   Zhi, Degui ^a   Eipers, Peter ^b   Goldsmith, Kelly T ^a   Dixon, Paula ^c   Crossman, David K ^a   Crowley, Michael R ^a   Lefkowitz, Elliot J ^a,d   Rodriguez, J Martin ^c   Morrow, Casey D ^b  

^a UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

^b UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

^c University of Alabama at Birmingham   (United States)

^d University of Alabama at Birmingham   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 85032282791     PISSN: None     EISSN: 20555008     Source Type: Journal    
DOI: 10.1038/s41522-017-0020-7     Document Type: Article

References (21)

1. He, M. et al. Emergence and global spread of epidemic healthcare-associated Clostridium difficile. Nat. Genet. 45, 109-113, doi: 10.1038/ng.2478 (2013).
2. Jagai, J. & Naumova, E. Clostridium difficile-associated disease in the elderly, United States. Emerg. Infect. Dis. 15, 343-344 (2009).
3. Kyne, L., Hamel, M. B., Polavaram, R. & Kelly, C. P. Health care costs and mortality associated with nosocomial diarrhea due to Clostridium difficile. Clin. Infect. Dis. 34, 346-353 (2002).
4. Seekatz, A. M. & Young, V. B. Clostridium difficile and the microbiota. J. Clin. Invest. 124, 4182-4189 (2014).
5. Louie, T. J. et al. Fidaxomicin versus vancomycin for Clostridium difficile infection. N. Engl. J. Med. 364, 422-431, doi: 10.1056/NEJMoa0910812 (2011).
6. Kelly, C. P. Fecal microbiota transplantation - an old therapy comes of age. N. Engl. J. Med. 368, 474-475 (2013).
7. Kumar, R. et al. Colonization potential to reconstitute a microbe community in patients detected early after fecal microbe transplant for recurrent C. difficile. BMC. Microbiol. 16, 5 (2016).
8. Petrof, E. O. et al. Stool substitute transplant therapy for the eradication of Clostridium difficile infection: 'RePOOPulating' the gut. Microbiome 1, 3 (2013).
9. Shahinas, D. et al. Toward an understanding of changes in diversity associated with fecal microbiome transplantation based on 16S rRNA gene deep sequencing. MBio 3, 1-7 (2012).
10. Shankar, V. et al. Species and genus level resolution analysis of gut microbiota in Clostridium difficile patients following fecal microbiota transplantation. Microbiome 2, 13 (2014).
11. Song, Y. et al. Microbiota dynamics in patients treated with fecal microbiota transplantation for recurrent Clostridium difficile infection. PloS ONE 8, e81330 (2013).
12. Li, S. S. et al. Durable coexistence of donor and ricipient strains after fecal microbiota transplantation. Science 352, 586-589 (2016).
13. Schloissnig, S. et al. Genomic variation landscape of the human gut microbiome. Nature 493, 45-50 (2013).
14. Van der Auwera, G. et al. From FastQ data to high confidence variant calls: The Genome Analysis Toolkit best practices pipeline. Curr. Protoc. Bioinformatics. 11, 1-33 (2013).
15. Li, H. & Durbin, R. Fast and accurate long-read alignment with Burrows-Wheeler transform. Bioinformatics 26, 589-595 (2010).
16. Segata, N. et al. Metagenomic microbial community profiling using unique clade-specific marker genes. Nat. Methods 9, 811-814, doi: 10.1038/nmeth.2066 (2012).
17. Lee, S. M. et al. Bacterial colonization factors control specificity and stability of the gut microbiota. Nature 501, 426-429 (2013).
18. Dunne, C. Adaptation of bacteria to the intestinal niche: Probiotics and gut disorder. Inflamm. Bowel. Dis. 7, 136-145 (2001).
19. Zhang, Y. Persisters, persistent infections and the Yin-Yang model. Emerg. Microbes. Infect 3, e3 (2014).
20. Landy, J. et al. Review article: Faecal transplantation therapy for gastrointestinal disease. Aliment. Pharmacol. Ther. 34, 409-415 (2011).
21. Lemon, K. P., Armitage, G. C., Relman, D. A. & Fischbach, M. A. Microbiota-targeted therapies: An ecological perspective. Sci. Transl. Med, 4, 137rv135 (2012).